ENZO BIOCHEM INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Enzo Biochem Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q2 2023.
  • Enzo Biochem Inc Deferred Tax Assets, Valuation Allowance for the quarter ending July 31, 2023 was $26.7M, a 22.9% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $26.7M -$7.93M -22.9% Jul 31, 2023 10-K 2023-11-03
Q2 2022 $34.6M +$4.74M +15.9% Jul 31, 2022 10-K 2023-11-03
Q2 2021 $29.9M -$203K -0.68% Jul 31, 2021 10-K 2022-10-14
Q2 2020 $30.1M +$6.55M +27.8% Jul 31, 2020 10-K 2021-10-12
Q2 2019 $23.5M -$944K -3.86% Jul 31, 2019 10-K 2020-10-19
Q2 2018 $24.5M +$24.4M +75008% Jul 31, 2018 10-K 2019-10-15
Q2 2017 $32.6K* -$34.9M -99.9% Jul 31, 2017 10-K 2018-10-15
Q2 2016 $34.9M -$14.7M -29.7% Jul 31, 2016 10-K 2017-09-27
Q2 2015 $49.7M +$193K +0.39% Jul 31, 2015 10-K 2016-10-13
Q2 2014 $49.5M +$1.84M +3.87% Jul 31, 2014 10-K 2015-10-13
Q2 2013 $47.6M +$6.36M +15.4% Jul 31, 2013 10-K 2014-10-09
Q2 2012 $41.3M +$8.34M +25.3% Jul 31, 2012 10-K 2013-10-15
Q2 2011 $32.9M Jul 31, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.